Both of these funds have made for good, market-beating investments over the past 10 years. But by focusing on the Nasdaq-100, which includes the top non-financial stocks on the exchange, the Invesco fund has been the far better investment during that stretch.

Biote: Revolutionizing Hormone Optimization Biote (NYSE: BTMD) represents an innovative play in the growing hormone optimization market.

Growth stocks have been all the rage in the post-pandemic era, and there’s a good chance that they could continue spearheading the market’s gains. The current economic fundamentals look solid, and some believe it is almost too good to be true.

There are some excellent opportunities for long-term investors as we head into 2025, and not just in beaten-down areas of the market like dividend stocks and real estate. In this video, Tyler Crowe and I discuss why these two growth stocks should be on your radar right now.